Search Result "D<sub>3</sub> receptor"
Actin and Keratin are Binding Partners of the 1,25D3-MARRS Receptor/PDIA3/ERp57
Journal: Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued)
Volume: 14 Issue: 2 Year: 2014 Page: 55-66
Author(s): Tremaine LeBlanc,Ilka Nemere
Modulators of Vitamin D Nuclear Receptor: Recent Advances from Structural Studies
Journal: Current Topics in Medicinal Chemistry
Volume: 14 Issue: 21 Year: 2014 Page: 2368-2377
Author(s): Anna Y. Belorusova,Natacha Rochel
Role of Dimerization in Dopamine D4 Receptor Biogenesis
Journal: Current Protein & Peptide Science
Volume: 15 Issue: 7 Year: 2014 Page: 659-665
Author(s): Kathleen Van Craenenbroeck,Dasiel O. Borroto-Escuela,Kamila Skieterska,Jolien Duchou,Wilber Romero-Fernandez,Kjell Fuxe
Development of Vitamin D Analogs Modulating the Pocket Structure of Vitamin D Receptor
Journal: Current Topics in Medicinal Chemistry
Volume: 14 Issue: 21 Year: 2014 Page: 2378-2387
Author(s): Keiko Yamamoto,Yasuaki Anami,Toshimasa Itoh
Effect of Vitamin D3 on Lifespan in Caenorhabditis elegans
Journal: Current Aging Science
Volume: 6 Issue: 3 Year: 2013 Page: 220-224
Author(s): Jennifer A. Messing,Roschelle Heuberger,Jennifer A. Schisa
Drugs that Interact with Receptors and Ion Channels
Ebook: Medicinal Chemistry - Fusion of Traditional and Western Medicine
Volume: 1 Year: 2013
Author(s): Robert E. Smith
Doi: 10.2174/9781608051496113010012
4D-QSAR Model for Compounds with Binding Affinity Towards Dopamine D2 Receptors
Journal: Letters in Drug Design & Discovery
Volume: 11 Issue: 5 Year: 2014 Page: 649-664
Author(s): Daniela Rodrigues Silva, Teodorico C. Ramalho, Elaine F. F. da Cunha
Modulation of γ2-MSH Hepatoprotection by Antisense Peptides and Melanocortin Subtype 3 and 4 Receptor Antagonists
Journal: Medicinal Chemistry
Volume: 11 Issue: 3 Year: 2015 Page: 286-295
Author(s): Petra Turcic, Nikola Stambuk, Pasko Konjevoda, Tomislav Kelava, Mario Gabricevic, Ranko Stojkovic, Gorana Aralica
When is a Proof-of-Concept (POC) not a POC? Pomaglumetad (LY2140023) as a Case Study for Antipsychotic Efficacy
Journal: Current Pharmaceutical Design
Volume: 21 Issue: 26 Year: 2015 Page: 3788-3796
Author(s): Gerard J. Marek
1, 25(OH)2D3 Inhibits Hepatocellular Carcinoma Development Through Reducing Secretion of Inflammatory Cytokines from Immunocytes
Journal: Current Medicinal Chemistry
Volume: 20 Issue: 3 Year: 2013 Page: 4131-4141
Author(s): Jian Guo, Zhenhua Ma, Qingyong Ma, Zheng Wu, Ping Fan, Xiaojie Zhou, Lulu Chen, Shuang Zhou, David Goltzman, Dengshun Miao, Erxi Wu